[Psychotropic drug therapy in children].
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001321:Autistic Disorder / Q000188:drug therapy; D002090:Butyrophenones / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002749:Chlorprothixene / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D004775:Enuresis / Q000188:drug therapy; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D008728:Methotrimeprazine / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use; D019965:Neurocognitive Disorders / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy; D010372:Pediatrics; D011300:Preoperative Care; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy; D013981:Tic Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D002090:Butyrophenones; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D014284:Triiodothyronine; D008774:Methylphenidate; D008728:Methotrimeprazine; D002749:Chlorprothixene
Psychopharmaka-Therapie im Kindesalter.